THROMBITENE

Serial Number 78243654
606

Registration Progress

Application Filed
Apr 30, 2003
Under Examination
Aug 2, 2005
Approved for Publication
Apr 20, 2005
Published for Opposition
May 10, 2005
Registered

Trademark Image

THROMBITENE

Basic Information

Serial Number
78243654
Filing Date
April 30, 2003
Published for Opposition
May 10, 2005
Abandonment Date
February 3, 2006
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 3, 2006
Classes
005

Rights Holder

KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.

03
Address
501 FIFTH STREET
BRISTOL, TN 37620

Ownership History

Jones Pharma Incorporated

Original Applicant
03
St. Louis, MO

KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.

New Owner Before Publication #1
03
BRISTOL, TN

KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.

Owner at Publication
03
BRISTOL, TN

Legal Representation

Attorney
Linda M. Buckley (Reg. No. 31,003)

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Apr 6, 2006 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 6, 2006 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Aug 2, 2005 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 10, 2005 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 20, 2005 NPUB O NOTICE OF PUBLICATION Loading...
Feb 23, 2005 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 26, 2005 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 24, 2005 ALIE A ASSIGNED TO LIE Loading...
Jan 12, 2005 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 8, 2004 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jun 9, 2004 MAIL I PAPER RECEIVED Loading...
Feb 18, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 18, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 30, 2003 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 30, 2003 GNSL F LETTER OF SUSPENSION E-MAILED Loading...

Detailed Classifications

Class 005
pharmaceutical hemostatic agents to control bleeding
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005